BDSI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 Mar 2022 @ 16:00):

Stats
Today's Volume	2.11M
Average Volume	3.35M
Market Cap	577.05M
EPS	$0.650 ( Q4 \| 2022-03-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	6.82 (Sector) 42.63 (Industry) 30.78
ATR14	$0.0920 (1.65%)

AERI 0.00%

ALVO 1.33%

ALVOW 6.79%

BDSI -0.09%

BFRIW -5.93%

CLVRW 0.00%

CYTHW -4.35%

ENDP 0.00%

GRVI 7.61%

HPCO 0.06%

INDV -1.59%

JUPWW -20.00%

LFCR -0.19%

LNDC -3.52%

LSDI -23.29%

PRFX -3.65%

PROCW 10.09%

QLI 6.82%

SBFMW 0.00%

SHOT 9.43%

SHPH 4.28%

Insider Trading

Date	Person	Action	Amount	type
2022-03-22	Watson W. Mark	Sell	54 740	Stock Options (right to buy)
2022-03-22	Watson W. Mark	Sell	90 663	Common Stock
2022-03-22	Vollins James	Sell	91 401	Restricted Stock Units
2022-03-22	Vollins James	Sell	29 826	Stock Options (right to buy)
2022-03-22	Vollins James	Sell	43 334	Stock Options (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 5 634 641 \| Sell: 24 333 206

Volume Correlation

Long: 0.22 (neutral)

Short: 0.00 (neutral)

Signal:(83.092) Neutral

BioDelivery Sciences Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioDelivery Sciences Correlation - Currency/Commodity

-0.27
( neutral )

-0.60
( weak negative )

-0.55
( weak negative )

0.60
( weak )

0.67
( moderate )

0.22
( neutral )

BioDelivery Sciences Financials

Annual	2021
Revenue:	$166.70M
Gross Profit:	$143.33M (85.98 %)
EPS:	$0.850

FY	2021
Revenue:	$166.70M
Gross Profit:	$143.33M (85.98 %)
EPS:	$0.850

FY	2020
Revenue:	$156.47M
Gross Profit:	$131.81M (84.24 %)
EPS:	$0.260

FY	2019
Revenue:	$111.39M
Gross Profit:	$89.80M (80.62 %)
EPS:	$-0.180

Financial Reports:

No articles found.

BioDelivery Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BioDelivery Sciences

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.